Page last updated: 2024-10-29

avapro and Carcinoma, Renal Cell

avapro has been researched along with Carcinoma, Renal Cell in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bamias, A1
Manios, E1
Karadimou, A1
Michas, F1
Lainakis, G1
Constantinidis, C1
Deliveliotis, C1
Zakopoulos, N1
Dimopoulos, MA1

Other Studies

1 other study available for avapro and Carcinoma, Renal Cell

ArticleYear
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancer.
    European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Antineoplastic Agents; Benzopyr

2011